Covid-19 Vaccine: Global Stock Market “Game Changer”

Bibliographic Information
Journal	Journal of Asian Multicultural Research for Economy and Management Study
Title	Covid-19 Vaccine: Global Stock Market “Game Changer”
Author(s)	Hartono, Hartono
Volume	2
Issue	2
Year	2021
Pages	8-17
DOI	10.47616/jamrems.v2i2.102
Full Text
URL	Link
Keywords	Covid-19 Vaccine, Investor Sentiment, Stock Market
Chicago 16th	Hartono, Hartono. "Covid-19 Vaccine: Global Stock Market “Game Changer”." Journal of Asian Multicultural Research for Economy and Management Study 2, no. 2 (2021).
APA 6th	Hartono, H. (2021). Covid-19 Vaccine: Global Stock Market “Game Changer”. Journal of Asian Multicultural Research for Economy and Management Study, 2(2).
MHRA	Hartono, Hartono. 2021. 'Covid-19 Vaccine: Global Stock Market “Game Changer”', Journal of Asian Multicultural Research for Economy and Management Study, 2.
MLA	Hartono, Hartono. "Covid-19 Vaccine: Global Stock Market “Game Changer”." Journal of Asian Multicultural Research for Economy and Management Study 2.2 (2021). Print.
Harvard	HARTONO, H. 2021. Covid-19 Vaccine: Global Stock Market “Game Changer”. Journal of Asian Multicultural Research for Economy and Management Study, 2.

Journal of Asian Multicultural Research for Economy and Management Study Volume 2 Issue 2 Contents

Global Economic Policy Response in Asean Welcomes Changes in Market Behavior Towards the New Normal Covid-19 Vaccine: Global Stock Market “Game Changer” The Pandemic Era Digital Economy: Youth Challenges in Social Media Marketing Effect of Compensation, Quality of Work Life on Performance Cryptocurrency Business Covers the Psychological Impact of the Business Market on the Youth Segment Relationship of Customer Relationship Learning to Service Quality of Regional Development Banks

Abstract

This research is a conceptual paper that examines the impact of the presence of the Covid-19 vaccine on investor sentiment and the performance of the global stock market after being hit by high concerns due to the pandemic. The results showed that each stage of vaccine development received high appreciation from stock investors, especially after vaccine candidates passed clinical trials in humans. Investors' positive sentiment towards the vaccine program boosted stock market performance. However, the sentiment of this vaccine cannot stand alone, it needs government policy support to truly restore market confidence in the recovery of social and economic conditions, including the stock market. This research combines secondary data published from high-ranking journals that can be used to help develop future tests.